As of May 6, we are no longer accepting new patients.

Low Dose Immunotherapy

Healthy Human T Cell

When I decided to treat Lyme patients I devoted myself to learning everything I could about current and emerging treatments. When I heard about Low Dose Immunotherapy (LDI), I was impressed by the elegance of how it works and the simplicity of the method. LDI attacks the root of the problem, immune dysfunction, instead of trying to kill off all the "bugs". LDI is a form of immune desensitization that works by restoring tolerance for various things. 

Symptoms are caused by inappropriate immune activation against the borrellia spirochete and / or the coinfections. The immune system then begins to relentlessly, but ineffectively attack these organisms, causing symptoms.

LDI enables us to approach this disease differently by treating it as an immune mediated disease. Our intervention with LDI is then directed at retraining the immune system to develop tolerance, which is many cases can stop symptoms, without needing to kill all the bacteria with long (or short courses of antibiotics). It is very difficult, and often impossible to eradicate the infection using antibiotics.

I no longer treat Lyme and coinfections with antibiotics, and I believe LDI is a better approach.  I stand on the shoulders of pioneer physicians, such as Dr. Bernard Raxlen, who decades ago treated an often debilitating mystery illness with the tools available to them, antibiotics, and helped many people. It is because of them that I am here today also offering treatment and hope.